Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial (2021)
Chaves, Leandro Jerez; Messias, André Márcio Vieira 
; Correa, Zelia; Jorge, Rodrigo
Source: Graefe's Archive for Clinical and Experimental Ophthalmology. Unidade: FMRP
Subjects: ELETRORRETINOGRAFIA, HEMANGIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Leandro Jerez et al. Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial. Graefe's Archive for Clinical and Experimental Ophthalmology, v. 259, p. 2837-2841, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00417-021-05153-9. Acesso em: 13 fev. 2026.APA
Chaves, L. J., Messias, A. M. V., Correa, Z., & Jorge, R. (2021). Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial. Graefe's Archive for Clinical and Experimental Ophthalmology, 259, 2837-2841. doi:10.1007/s00417-021-05153-9NLM
Chaves LJ, Messias AMV, Correa Z, Jorge R. Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial [Internet]. Graefe's Archive for Clinical and Experimental Ophthalmology. 2021 ; 259 2837-2841.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s00417-021-05153-9Vancouver
Chaves LJ, Messias AMV, Correa Z, Jorge R. Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial [Internet]. Graefe's Archive for Clinical and Experimental Ophthalmology. 2021 ; 259 2837-2841.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s00417-021-05153-9
